Aurinia Pharmaceuticals Inc (AUPH)
9.20
-0.05
(-0.54%)
USD |
NASDAQ |
Dec 27, 16:00
9.215
+0.02
(+0.16%)
After-Hours: 20:00
Aurinia Pharmaceuticals Cash from Investing (Quarterly): -10.57M for Sept. 30, 2024
Cash from Investing (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Investing (Quarterly) Benchmarks
| Edesa Biotech Inc | -- |
| Lexaria Bioscience Corp | -0.0696M |
| Xenon Pharmaceuticals Inc | 1.98M |
| ESSA Pharma Inc | 21.02M |
| ImmunoPrecise Antibodies Ltd | -0.0482M |
Cash from Investing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | 17.03M |
| Cash from Financing (Quarterly) | -2.722M |
| Free Cash Flow | 28.30M |
| Free Cash Flow Per Share (Quarterly) | 0.116 |
| Free Cash Flow to Equity (Quarterly) | 16.90M |
| Free Cash Flow to Firm (Quarterly) | 16.90M |
| Free Cash Flow Yield | 2.13% |